Skip to main content
Log in

Removal of 106 amino acids from the N-terminus of UDP-GlcNAc :alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I does not inactivate the enzyme

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

UDP-GlcNAc : α-3-D-mannoside β-1,2-N-acetylglucosaminyltransferase I (GnT I, EC 2.4.1.101) plays an essential role in the conversion of oligomannose to complex and hybrid N-glycans. Rabbit GnTI is 447 residues long and has a short four-residue N-terminal cytoplasmic tail, a 25-residue putative signal–anchor hydrophobic domain, a stem region of undetermined length and a large C-terminal catalytic domain, a structure typical of all glycosyltransferases cloned to date. Comparison of the amino acid sequences for human, rabbit, mouse, rat, chicken, frog and Caenorhabditis elegans GnT I was used to obtain a secondary structure prediction for the enzyme which suggested that the location of the junction between the stem and the catalytic domain was at about residue 106. To test this hypothesis, several hybrid constructs containing GnT I with N- and C-terminal truncations fused to a mellitin signal sequence were inserted into the genome of Autographa californica nuclear polyhedrosis virus (AcMNPV), Sf 9 insect cells were infected with the recombinant baculovirus and supernatants were assayed for GnT I activity. Removal of 29, 84 and 106 N-terminal amino acids had no effect on GnT I activity; however, removal of a further 14 amino acids resulted in complete loss of activity. Western blot analysis showed strong protein bands for all truncated enzymes except for the construct lacking 120 N-terminal residues indicating proteolysis or defective expression or secretion of this protein. The data indicate that the stem is at least 77 residues long.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reglero A, Rodriguez-Aparicio LB, Lueno JM (1993) Int J Bio-chem 25: 1517-27.

    Google Scholar 

  2. Harduin-Lepers A, Recchi MA, Delannoy P (1995) Glycobiol-ogy 5: 741-58.

    Google Scholar 

  3. Livingston BD, Paulson JC (1993) J Biol Chem 268: 11504-7.

    PubMed  Google Scholar 

  4. Fryer HJL, Hockfield S (1996) Current Opin Neurobiol 6: 113-16.

    Google Scholar 

  5. Coughlan CM, Seckl JR, Fox DJ, Unsworth R, Breen KC (1996) Glycobiology 6: 15-22.

    PubMed  Google Scholar 

  6. Maguire TM, Breen KC (1995) Dementia 6: 185-90.

    PubMed  Google Scholar 

  7. Maguire TM, Thakore J, Dinan TG, Hopwood S, Breen KC (1997) Biol Psychiatry: In press.

  8. Hayes FD, Breen KC (1994) Toxic in vitro 8: 407-11.

    Google Scholar 

  9. Munro S (1991) EMBO J 12: 3577-88.

    Google Scholar 

  10. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1993) In Current Protocols in Molecular Biology (Janssen K ed.) New York: John Wiley and Sons, Inc.

    Google Scholar 

  11. Breen KC, Regan CM (1986) J Neurochem 47: 1176-80.

    PubMed  Google Scholar 

  12. Coughlan CM, Seckl JM, Breen KC (1996) Cell Mol Neurobiol 16: 431-6.

    Google Scholar 

  13. Skoza L, Mohos S (1976) Biochem J 159: 457-62.

    PubMed  Google Scholar 

  14. Martin ML, Breen KC, Regan CM (1988) Tox in vitro 2: 43-8.

    Google Scholar 

  15. Wang XC, O'Hanlon TP, Lau JTY (1989) J Biol Chem 264: 1854-9.

    PubMed  Google Scholar 

  16. Livingston BD, De Robertis EM, Paulson JC (1990) Glycobiol-ogy 1: 39-44.

    Google Scholar 

  17. Lee EU, Roth J, Paulson JC (1989) J Biol Chem 264: 13848-55.

    PubMed  Google Scholar 

  18. Nakagawa H, Zheng MZ, Hakomori S, Tsukamoto Y, Kawamura Y, Takahashi N (1996) Eur J Biochem 237: 76-85.

    PubMed  Google Scholar 

  19. Veiga SS, Chammas R, Cella N, Brentani RR (1995) Int J Cancer 61: 420-4.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarkar, M., Pagny, S., Unligil, U. et al. Removal of 106 amino acids from the N-terminus of UDP-GlcNAc :alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I does not inactivate the enzyme. Glycoconj J 15, 193–197 (1998). https://doi.org/10.1023/A:1006928624913

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006928624913

Navigation